Reuben Virdee’s Journey

Reuben was a happy two year old, playing with his friends at birthday parties, attending pre-school and enjoying his new role as big brother to little Hari. In December 2016 when he was really looking forward to Father Christmas visiting, his family’s world was turned upside down when he was diagnosed with high-risk neuroblastoma.

Reuben has since spent his 3rd and 4th birthdays, as well as countless other special days, in hospital receiving treatment.  His mum, Jess, says:

“We always struggled to watch adverts on TV about families being told their loved ones had cancer, and never really imagined how it must feel to hear those words. But now it’s our reality – our precious little boy has high-risk neuroblastoma. We became one of those families.”

Neuroblastoma is a rare childhood cancer affecting fewer than 100 children in the UK each year. As in 50% of cases of high-risk metastatic neuroblastoma, by the time Reuben’s primary tumour was found in his tummy, it had already spread to his bones and bone marrow.

The impact has been immense.  His dad, Kulwant, says:

“Our family has spent the majority of the last 17 months separated. Reuben has missed out on so many opportunities just to be a child. At the worst times, it’s felt like he was fading in front of our eyes when he’s been silent, unable to gather the energy to make a sound and in too much pain from the side effects of treatment to speak. Despite all of this he keeps us on our toes with his cheeky sense of humour. We’re so incredibly proud of him. He’s endured what no child should have to, fighting every step of the way and showing his fierce strength of character and fighting spirit!”

Now free from the disease, Reuben’s family will take him to New York several times over the next year to receive a clinical trial called the Bivalent Vaccine, with the aim of helping keep his cancer away. Whilst he’s taking part in this trial and for the following year afterwards, he will need a number of additional assessments and scans, plus in the future, it’s likely he will have many long-term medical needs as a result of receiving such harsh and toxic treatment.  This is why his family need your help to continue to raise funds for his care.


Read more about Reuben's story...


Reuben’s fundraising campaign

High-risk neuroblastoma has a high rate of the cancer returning, and if this happens just 1 in 10 children survive. Whilst Reuben is taking part in the bivalent vaccine trial and for the years afterwards, he will need many additional assessments and scans. Reuben’s family are fundraising for any further treatment and care that he may need in the future, that isn’t available through the NHS.

Supporting Reuben’s fundraising campaign will help ensure his parents are able to give their little boy the best possible chance of beating this disease.


How you can help

There are many ways you can help Reuben: by making a personal donation; holding a fundraising event; getting sponsored to take on a challenge; or simply following and sharing Reuben’s story through his Facebook page, @ReubensFight.

Download our free Reuben resources (below) to support your fundraising, and CLICK HERE for even more resources, including fundraising ideas, templates and guidance.

Campaign Poster

Event Poster

Sponsorship Form


You can make a donation via this page, or if you’d prefer to text donate, text VRDE55 and your amount £1 – £10 to 70070. If you’d like help supporting Reuben’s campaign, please get in touch with the fundraising team on 0207 284 0800

Terms and Conditions for Journeys

All donations are paid into Solving Kids’ Cancer’s (SKC) general funds to further its general charitable purposes. The funds raised by this Journey are not restricted for the child’s use. However, the trustees of SKC have agreed to designate 90% of funds raised by this Journey to help the child and their family pay for potential future treatment costs and all other associated costs including travel and accommodation. We will use the remaining 10% to pay for SKC’s administrative and fundraising costs.

If the child no longer needs the funds, or if the trustees decide, at their absolute discretion, that the funds should be used for a different purpose, they may redesignate all or part of the 90% for SKC general charitable purposes. We are very grateful for your charitable donation.

For further information about SKC and how we spend donations, please contact

Solving Kids' Cancer Europe a registered charity no. 1135601 and registered company no. 7208648.

Join our newsletter

For information and guidance on how Solving Kids’ Cancer manages your personal information please see our Privacy Policy

Privacy Policy (click to expand)

Follow Us

Useful links

Contact us

Solving Kids' Cancer

Tel: 020 7284 0800

CAN Mezzanine
49-51 East Road
N1 6AH

Contact us